Closed · RFA-HL-14-026 · CFDA 93.839 · Discretionary

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients SBIR (R43/R44)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

Varies
Award range
Closed
Status
February 10, 2015
Close date
-
Expected awards

The verdict

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients SBIR (R43/R44) is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

Varies
award range
Closed
application status
93.839
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Development of a Microfluidic Platform for Bl… is closed (last close February 10, 2015). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 10, 2015

Posted Nov 18 Closes Feb 10

Instrument

Grant

Description

This FOA encourages applications to develop microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients. Platforms should support clinical and/or research applications. Microfluidic designs that are multifunctional, with the capacity to perform multiple assays on a single blood sample, are of interest. Use of these devices could significantly reduce levels of phlebotomy-induced blood loss in pediatric/neonatal patients.

Small-business / for-profit corridor · RFA-HL-14-026

Development of a Microfluidic Platform for Bl… prints a for-profit / small-business applicant door (Small businesses). Treat the listing as business-facing unless the full Grants.gov announcement narrows it further. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). 789 other National Institutes of Health listings share this eligibility-code string (6% of 12,420).

Code 23
Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Development of a Microfluidic Platform for Bl… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.839 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants